Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is United States  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Morrison AC, Fornage M, Liao D, Boerwinkle E. "Parental history of stroke predicts subclinical but not clinical stroke: the Atherosclerosis Risk in Communities Study." Stroke. 2000;31(9):2098-102.
Shahar E, Folsom AR, Romm FJ, et al. "Patterns of aspirin use in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study." Am Heart J. 1996;131(5):915-22.
Lutsey PL, Folsom AR, Heckbert SR, Cushman M. "Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study." J Thromb Haemost. 2009;7(10):1639-48.
Grams ME, Waikar SS, MacMahon B, Whelton S, Ballew SH. "Performance and limitations of administrative data in the identification of AKI." Clin J Am Soc Nephrol. 2014;9(4):682-9.
Kshirsagar AV, Moss KL, Elter JR, Beck JD, Offenbacher S, Falk RJ. "Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk In Communities (ARIC) study." Am J Kidney Dis. 2005;45(4):650-7.
Southerland JH, Moss K, Taylor GW, et al. "Periodontitis and diabetes associations with measures of atherosclerosis and CHD." Atherosclerosis. 2012;222(1):196-201.
Kalbaugh CA, Kucharska-Newton AMaria, Wruck L, et al. "Peripheral Artery Disease Prevalence and Incidence Estimated From Both Outpatient and Inpatient Settings Among Medicare Fee-for-Service Beneficiaries in the Atherosclerosis Risk in Communities (ARIC) Study." J Am Heart Assoc. 2017;6(5).
Volcik KA, Nettleton JA, Ballantyne CM, Boerwinkle E. "Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study." Am J Clin Nutr. 2008;87(6):1926-31.
Evenson KR, Rosamond WD, Cai J, et al. "Physical activity and ischemic stroke risk. The atherosclerosis risk in communities study." Stroke. 1999;30(7):1333-9.
Dubbert PM, Penman AD, Evenson KR, Reeves RR, Mosley TH. "Physical activity and subclinical MRI cerebral infarcts: the ARIC Study." J Neurol Sci. 2009;284(1-2):135-9.
Huxley RR, Misialek JR, Agarwal SK, Loehr LR, Soliman EZ, Chen LYee. "Physical activity, obesity, weight change, and risk of atrial fibrillation: the Atherosclerosis Risk in Communities study." Circ Arrhythm Electrophysiol. 2014;7(4):620-5.
Florido R, Zhao D, Ndumele CE, et al. "Physical Activity, Parental History of Premature Coronary Heart Disease, and Incident Atherosclerotic Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study." J Am Heart Assoc. 2016;5(9).
Gabriel KPettee, Griswold ME, Wang W, et al. "Physical activity trajectories and subsequent fall risk: ARIC Study." Prev Med. 2019;121:40-46.
Burke BTeevan, Köttgen A, Law A, et al. "Physical Function, Hyperuricemia, and Gout in Older Adults." Arthritis Care Res (Hoboken). 2015;67(12):1730-8.
Kim H, Caulfield LE, Garcia-Larsen V, Steffen LM, Coresh JJ. "Plant-Based Diets Are Associated With a Lower Risk of Incident Cardiovascular Disease, Cardiovascular Disease Mortality, and All-Cause Mortality in a General Population of Middle-Aged Adults." J Am Heart Assoc. 2019;8(16):e012865.
Folsom AR, Tang W, Basu S, Misialek JR, Couper DJ, Heckbert SR. "Plasma Concentrations of High Molecular Weight Kininogen and Prekallikrein and Venous Thromboembolism Incidence in the General Population." Thromb Haemost. 2019;119(5):834-843.
Yamagishi K, Folsom AR. "Plasma fatty acid composition and incident ischemic stroke in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study." Cerebrovasc Dis. 2013;36(1):38-46.
Iso H, Folsom AR, Sato S, et al. "Plasma fibrinogen and its correlates in Japanese and US population samples." Arterioscler Thromb. 1993;13(6):783-90.
Rebholz CM, Selvin E, Liang M, et al. "Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease." Kidney Int. 2018;93(1):252-259.
Juraschek SP, Selvin E, Miller ER, Brancati FL. "Plasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities study." Ann Epidemiol. 2013;23(12):791-796.e4.
Brown SA, Hutchinson R, Morrisett J, et al. "Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study." Arterioscler Thromb. 1993;13(8):1139-58.
Shahar E, Chambless LE, Rosamond WD, et al. "Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study." Stroke. 2003;34(3):623-31.
Hoogeveen RC, Morrison A, Boerwinkle E, et al. "Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study." Atherosclerosis. 2005;183(2):301-7.
Chen H, Mosley TH, Alonso A, Huang X. "Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study." Am J Epidemiol. 2009;169(9):1064-9.
Greenberg KI, McAdams-Demarco MA, Köttgen A, Appel LJ, Coresh JJ. "Plasma Urate and Risk of a Hospital Stay with AKI: The Atherosclerosis Risk in Communities Study." Clin J Am Soc Nephrol. 2015;10(5):776-83.
Broda G, Davis CE, Pajak A, et al. "Poland and United States Collaborative Study on Cardiovascular Epidemiology. A comparison of HDL cholesterol and its subfractions in populations covered by the United States Atherosclerosis Risk in Communities Study and the Pol-MONICA Project." Arterioscler Thromb Vasc Biol. 1996;16(2):339-49.
Avery CL, Loehr LR, Baggett C, et al. "The population burden of heart failure attributable to modifiable risk factors: the ARIC (Atherosclerosis Risk in Communities) study." J Am Coll Cardiol. 2012;60(17):1640-6.
Liao D, Evans GW, Chambless LE, et al. "Population-based study of heart rate variability and prevalent myocardial infarction. The Atherosclerosis Risk in Communities Study." J Electrocardiol. 1996;29(3):189-98.
Bush M, Sturmer T, Stearns SC, Simpson RJ, M Brookhart A, Rosamond WD. "Position matters: Validation of medicare hospital claims for myocardial infarction against medical record review in the atherosclerosis risk in communities study." Pharmacoepidemiol Drug Saf. 2018;27(10):1085-1091.
Yatsuya H, Folsom AR, Alonso A, Gottesman RF, Rose KM. "Postural changes in blood pressure and incidence of ischemic stroke subtypes: the ARIC study." Hypertension. 2011;57(2):167-73.
Loehr LR, Rosamond WD, Poole C, et al. "The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study." Am J Epidemiol. 2010;172(7):781-9.
Morrison AC, Bare LA, Chambless LE, et al. "Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2007;166(1):28-35.
Agarwal SK, Chambless LE, Ballantyne CM, et al. "Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study." Circ Heart Fail. 2012;5(4):422-9.
Chambless LE, Heiss G, Shahar E, Earp M J, Toole J. "Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2004;160(3):259-69.
Santos ABS, Gupta DK, Bello NA, et al. "Prehypertension is Associated With Abnormalities of Cardiac Structure and Function in the Atherosclerosis Risk in Communities Study." Am J Hypertens. 2016;29(5):568-74.
Mok Y, Sang Y, Ballew SH, et al. "Premorbid levels of high-sensitivity cardiac troponin T and natriuretic peptide and prognosis after incident myocardial infarction." Am Heart J. 2019;216:62-73.
Bryan RN, Cai J, Burke G, et al. "Prevalence and anatomic characteristics of infarct-like lesions on MR images of middle-aged adults: the atherosclerosis risk in communities study." AJNR Am J Neuroradiol. 1999;20(7):1273-80.
Rooney MR, Soliman EZ, Lutsey PL, et al. "Prevalence and Characteristics of Subclinical Atrial Fibrillation in a Community-Dwelling Elderly Population: The ARIC Study." Circ Arrhythm Electrophysiol. 2019;12(10):e007390.
Rawlings AM, Sharrett ARichey, Golden SH, Windham BG. "Prevalence and correlates of depressive symptoms in older adults across the glycaemic spectrum: the Atherosclerosis Risk in Communities (ARIC) study." Diabet Med. 2018;35(5):583-587.
Diab N, Daya NR, Juraschek SP, et al. "Prevalence and Risk Factors of Thyroid Dysfunction in Older Adults in the Community." Sci Rep. 2019;9(1):13156.
Liao D, Cooper L, Cai J, et al. "The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study." Neuroepidemiology. 1997;16(3):149-62.
Parrinello CM, Rastegar I, Godino JG, Miedema MD, Matsushita K. "Prevalence of and Racial Disparities in Risk Factor Control in Older Adults With Diabetes: The Atherosclerosis Risk in Communities Study." Diabetes Care. 2015;38(7):1290-8.
Dong J, Pinto JM, Guo X, et al. "The Prevalence of Anosmia and Associated Factors Among U.S. Black and White Older Adults." J Gerontol A Biol Sci Med Sci. 2017;72(8):1080-1086.
Loehr LR, Soliman EZ, Poon AK, et al. "The prevalence of atrial fibrillation on 48-hour ambulatory electrocardiography in African Americans compared to Whites: The Atherosclerosis Risk in Communities (ARIC) study." Am Heart J. 2019;216:1-8.
Schneider ALC, Wang D, Gottesman RF, Selvin E. "Prevalence of Disability Associated With Head Injury With Loss of Consciousness in Adults in the United States: A Population-Based Study." Neurology. 2021;97(2):e124-e135.
Suri MFareed K, Qiao Y, Ma X, et al. "Prevalence of Intracranial Atherosclerotic Stenosis Using High-Resolution Magnetic Resonance Angiography in the General Population: The Atherosclerosis Risk in Communities Study." Stroke. 2016;47(5):1187-93.
Toole JF, Chambless LE, Heiss G, Tyroler HA, Paton CC. "Prevalence of stroke and transient ischemic attacks in the Atherosclerosis Risk in Communities (ARIC) study." Ann Epidemiol. 1993;3(5):500-3.
Garaas R, Moss KL, Fisher EL, et al. "Prevalence of visible third molars with caries experience or periodontal pathology in middle-aged and older Americans." J Oral Maxillofac Surg. 2011;69(2):463-70.
Smith JW, O'Neal WT, M Shoemaker B, Chen LYee, Alonso A, S Whalen P. "PR-Interval Components and Atrial Fibrillation Risk (from the Atherosclerosis Risk in Communities Study)." Am J Cardiol. 2017;119(3):466-472.
Shuldiner AR, Nguyen W, Kao WH, et al. "Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity." Diabetes Care. 2000;23(1):126-7.
Kao LWH, Coresh J, Shuldiner AR, Boerwinkle E, Bray MS, Brancati FL. "Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study." Diabetes. 2003;52(6):1568-72.
Crow RS, Hannan PJ, Folsom AR. "Prognostic significance of corrected QT and corrected JT interval for incident coronary heart disease in a general population sample stratified by presence or absence of wide QRS complex: the ARIC Study with 13 years of follow-up." Circulation. 2003;108(16):1985-9.
Zhang Z-M, Prineas RJ, Soliman EZ, Baggett C, Heiss G. "Prognostic significance of serial Q/ST-T changes by the Minnesota Code and Novacode in the Atherosclerosis Risk in Communities (ARIC) study." Eur J Prev Cardiol. 2012;19(6):1430-6.
Seidelmann SB, Vardeny O, Claggett B, et al. "An Promoter Polymorphism Associated With Elevated N-Terminal pro-B-Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality." J Am Heart Assoc. 2017;6(4).
Kan H, Heiss G, Rose KM, Whitsel EA, Lurmann F, London SJ. "Prospective analysis of traffic exposure as a risk factor for incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study." Environ Health Perspect. 2008;116(11):1463-8.
Polter EJ, Onyeaghala G, Lutsey PL, Folsom AR, Joshu CE, Platz EA. "Prospective Association of Serum and Dietary Magnesium with Colorectal Cancer Incidence." Cancer Epidemiol Biomarkers Prev. 2019;28(8):1292-1299.
Folsom AR, Rasmussen ML, Chambless LE, et al. "Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Diabetes Care. 1999;22(7):1077-83.
Carnethon MR, Anthony MS, Cascio WE, et al. "A prospective evaluation of the risk of QT prolongation with hormone replacement therapy: the atherosclerosis risk in communities study." Ann Epidemiol. 2003;13(7):530-6.
Folsom AR, Tang W, Roetker NS, Heckbert SR, Cushman M. "Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE)." Am J Hematol. 2015;90(11):1047-51.
Roetker NS, Maclehose RF, Hoogeveen RC, Ballantyne CM, Basu S, Cushman M. "Prospective Study of Endogenous Hormones and Incidence of Venous Thromboembolism: The Atherosclerosis Risk in Communities Study." Thromb Haemost. 2018;118(11):1940-1950.
Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK. "Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study." Arterioscler Thromb Vasc Biol. 2001;21(4):611-7.
Kubota Y, Folsom AR, Matsushita K, Couper DJ. "Prospective study of lung function and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study." Atherosclerosis. 2018;268:225-230.
Jehn ML, Guallar E, Clark JM, et al. "A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Epidemiol. 2007;165(9):1047-54.
Folsom AR, Cushman M, Rasmussen-Torvik LJ, Heckbert SR, Tsai MY. "Prospective study of polymorphisms of the protein Z-dependent protease inhibitor and risk of venous thromboembolism." Thromb Haemost. 2007;97(3):493-4.
Folsom AR, Tang W, Roetker NS, et al. "Prospective study of sickle cell trait and venous thromboembolism incidence." J Thromb Haemost. 2015;13(1):2-9.
Folsom AR, Cushman M, Tsai MY, Heckbert SR, Aleksic N. "Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism." Am J Hematol. 2002;71(4):285-90.
Folsom AR, Tang W, George KM, Heckbert SR, Maclehose RF, Cushman M. "Prospective study of γ' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE)." Thromb Res. 2016;139:44-9.
Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh JJ. "Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease." JAMA Intern Med. 2016;176(2):238-46.
Kritchevsky SB, Tell GS, Shimakawa T, et al. "Provitamin A carotenoid intake and carotid artery plaques: the Atherosclerosis Risk in Communities Study." Am J Clin Nutr. 1998;68(3):726-33.
Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Wu KK, Boerwinkle E. "P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the Atherosclerosis Risk in Communities Study." Atherosclerosis. 2006;186(1):74-9.
Teramoto K, Santos M, Claggett B, et al. "Pulmonary vascular dysfunction among people aged over 65 years in the community in the Atherosclerosis Risk In Communities (ARIC) Study: A cross-sectional analysis." PLoS Med. 2020;17(10):e1003361.
Magnani JW, Zhu L, Norby FL, et al. "P-wave indices and atrial fibrillation: cross-cohort assessments from the Framingham Heart Study (FHS) and Atherosclerosis Risk in Communities (ARIC) study." Am Heart J. 2015;169(1):53-61.e1.
Q
Blecker S, Agarwal SK, Chang PP, et al. "Quality of care for heart failure patients hospitalized for any cause." J Am Coll Cardiol. 2014;63(2):123-30.
R
Lutsey PL, Michos ED, Misialek JR, et al. "Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study." JACC Heart Fail. 2015;3(5):347-356.
Evans K, Coresh J, Bash LD, et al. "Race differences in access to health care and disparities in incident chronic kidney disease in the US." Nephrol Dial Transplant. 2011;26(3):899-908.
Williams JE, Couper DJ, Din-Dzietham R, Nieto JF, Folsom AR. "Race-gender differences in the association of trait anger with subclinical carotid artery atherosclerosis: the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2007;165(11):1296-304.
Zakai NA, McClure LA, Judd SE, Safford MM, Folsom AR, Lutsey PL. "Racial and regional differences in venous thromboembolism in the United States in 3 cohorts." Circulation. 2014;129(14):1502-9.
Negi SI, Pankow JS, Fernstrom K, et al. "Racial differences in association of elevated interleukin-18 levels with type 2 diabetes: the Atherosclerosis Risk in Communities study." Diabetes Care. 2012;35(7):1513-8.
Maynard JW, McAdams-Demarco MA, Law A, Kao L, Gelber AC, Coresh JJ. "Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2014;179(5):576-83.
Naorungroj S, Slade GD, Divaris K, Heiss G, Offenbacher S. "Racial differences in periodontal disease and 10-year self-reported tooth loss among late middle-aged and older adults: the dental ARIC study." J Public Health Dent. 2017;77(4):372-382.

Pages